Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors.

Por Voltarelli, J C, Gjerset, G, Anasetti, C
Publicado em 1993

Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells

Por ZHU, L, YU, X, AKATSUKA, Y, COOPER, J A, ANASETTI, C
Publicado em 1999

Boosting humoral and cellular immunity to pneumococcus by vaccination before and just after autologous transplant for myeloma

Por Locke, FL, Menges, M, Nishihori, T, Nwoga, C, Alsina, M, Anasetti, C
Publicado no Bone Marrow Transplant (2015)

Practice variation in physician referral for allogeneic hematopoietic cell transplantation

Por Pidala, J, Craig, B, Lee, SJ, Majhail, N, Quinn, G, Anasetti, C
Publicado em 2012

Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity

Por Pidala, J, Kim, J, Anasetti, C, Kharfan-Dabaja, MA, Field, T, Perkins, J, Ayala, E, Perez, L, Fernandez, H
Publicado no Bone Marrow Transplant (2010)

Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma

Por Nishihori, T, Ochoa-Bayona, JL, Kim, J, Pidala, J, Shain, K, Baz, R, Sullivan, D, Jim, HS, Anasetti, C, Alsina, M
Publicado no Bone Marrow Transplant (2013)

Recent Decrease in Acute GVHD in Children with Leukemia Receiving Unrelated Donor Bone Marrow Transplants

Por Davies, SM, Wang, D, Wang, T, Arora, M, Ringden, O, Anasetti, C, Pavletic, S, Casper, J, MacMillan, ML, Sanders, J, Wall, D, Kernan, NA
Publicado em 2009

Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience

Por Nelson, R, Shapiro, JF, Perkins, JB, Kim, J, Nishihori, T, Pidala, J, Ayala, E, Locke, FL, Field, T, Mishra, A, Riches, M, Betts, B, Perez, L, Yue, B, Ochoa-Bayona, JL, Alsina, M, Fernandez, H, Anasetti, C, Kharfan-Dabaja, MA
Publicado no Bone Marrow Transplant (2015)

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization

Por Pidala, J, Kim, J, Schell, M, Lee, SJ, Hillgruber, R, Nye, V, Ayala, E, Alsina, M, Betts, B, Bookout, R, Fernandez, HF, Field, T, Locke, FL, Nishihori, T, Ochoa, JL, Perez, L, Perkins, J, Shapiro, J, Tate, C, Tomblyn, M, Anasetti, C
Publicado no Bone Marrow Transplant (2012)